Related references
Note: Only part of the references are listed.The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions
Stephen P. Burr et al.
Cell Metabolism (2016)
Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells
Oliver D. K. Maddocks et al.
MOLECULAR CELL (2016)
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling
Xudong Fu et al.
CELL METABOLISM (2015)
Mitochondria as biosynthetic factories for cancer proliferation
Christopher S. Ahn et al.
CANCER & METABOLISM (2015)
HIF-1-Dependent Induction of Jumonji Domain-Containing Protein (JMJD) 3 under Hypoxic Conditions
Ho-Youl Lee et al.
MOLECULES AND CELLS (2014)
MetSizeR: selecting the optimal sample size for metabolomic studies using an analysis based approach
Gift Nyamundanda et al.
BMC BIOINFORMATICS (2013)
Stem cell-based therapy for malignant glioma
Daniel Bexell et al.
CANCER TREATMENT REVIEWS (2013)
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
Julie-Aurore Losman et al.
GENES & DEVELOPMENT (2013)
An R132H Mutation in Isocitrate Dehydrogenase 1 Enhances p21 Expression and Inhibits Phosphorylation of Retinoblastoma Protein in Glioma Cells
Satsuki Miyata et al.
NEUROLOGIA MEDICO-CHIRURGICA (2013)
HMDB 3.0-The Human Metabolome Database in 2013
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2013)
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
Paul Guilhamon et al.
NATURE COMMUNICATIONS (2013)
Bevacizumab for the treatment of high-grade glioma
Mustafa Khasraw et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Serine is a natural ligand and allosteric activator of pyruvate kinase M2
Barbara Chaneton et al.
NATURE (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production
P. S. Ward et al.
ONCOGENE (2012)
A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism
Patricia B. S. Celestino-Soper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Glioma-derived mutations in isocitrate dehydrogenase 2 beneficial to traditional chemotherapy
Yuejun Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Rasheduzzaman Chowdhury et al.
EMBO REPORTS (2011)
Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas
Serena Pellegatta et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma Clinical article
Yoshihiro Muragaki et al.
JOURNAL OF NEUROSURGERY (2011)
DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma
Brock C. Christensen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Zachary J. Reitman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Stefan Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Share Paper
